This review discusses the management of venous thromboembolism during pregnancy, highlighting the lack of prospective clinical trials to guide therapy.
Answers are grounded in this paper and cite their sources.
Expert opinion currently guides VTE management in pregnancy; leaves open the urgent need for prospective trials to establish evidence-based standards.
Venous thromboembolism is an uncommon but leading cause of illness and death during pregnancy and the puerperium.1,2 It has been reported to occur in 1 in 1000 to 1 in 2000 pregnancies,3,4 although few studies have used objective diagnostic techniques. Over the past two decades, there has been considerable change in the management of venous thromboembolism in nonpregnant patients. Moreover, our understanding of changes in the coagulation system during pregnancy has increased. However, the management of venous thromboembolism during pregnancy remains a subject of controversy because of the lack of prospective clinical trials. In this article, we will . . .
No takes yet. Share an insight, caveat, or question.
Toglia et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: